Xia Mao
Guilin Medical University(CN)Regeneron (United States)(US)Guizhou Cancer Hospital(CN)Hubei Provincial Center for Disease Control and Prevention(CN)First Hospital of China Medical University(CN)Henan Forestry Vocational College(CN)Tongji Hospital(CN)Huazhong University of Science and Technology(CN)China Medical University(CN)
Publications by Year
Research Areas
CAR-T cell therapy research, Lymphoma Diagnosis and Treatment, Multiple Myeloma Research and Treatments, Acute Myeloid Leukemia Research, Immune Cell Function and Interaction
Most-Cited Works
- → Efficacy and safety of CAR19/22 T-cell cocktail therapy in patients with refractory/relapsed B-cell malignancies(2019)257 cited
- → A phase 1 study of a novel fully human BCMA-targeting CAR (CT103A) in patients with relapsed/refractory multiple myeloma(2021)206 cited
- → Integrated genomic analysis identifies deregulated JAK/STAT-MYC-biosynthesis axis in aggressive NK-cell leukemia(2017)96 cited
- → Inflammatory signatures for quick diagnosis of life-threatening infection during the CAR T-cell therapy(2019)71 cited
- → A phase I study of anti‐BCMA CAR T cell therapy in relapsed/refractory multiple myeloma and plasma cell leukemia(2021)68 cited
- → CD19/CD22 Chimeric Antigen Receptor T Cell Cocktail Therapy following Autologous Transplantation in Patients with Relapsed/Refractory Aggressive B Cell Lymphomas(2021)63 cited